Gufic Biosciences balance sheet

As of Mar 2026

Total assets: ₹1,342cr+14.8% on Mar 2025
Shareholders' equity: ₹665cr+10.6% on Mar 2025
Total debt: ₹385cr+24.1% on Mar 2025
Cash and investments: ₹62.2cr+295.5% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	485	500	153	159
	22.1	21.8	307	170
	6.2	6.3	5.6	—
	1.8	1.8	1.8	0.8
	0.5	0.2	0.4	0.3
	24.8	9.7	8.9	—
	27.1	11.7	11.1	—
	—	5.3	15.0	57.7
	540	545	492	397
	324	217	200	183
	297	315	330	205
	62.2	15.7	1.1	28.6
	14.0	13.3	12.3	18.1
	0.7	0.3	0.4	0.2
	—	62.1	0.0	—
	374	406	344	252
	102	0.0	56.2	28.3
	802	625	600	464
	1,342	1,169	1,093	861
Equity
	10.0	10.0	10.0	9.7
	655	591	523	338
	665	601	533	348
	0.0	0.0	—	—
	665	601	533	348
Liabilities
	105	130	154	191
	19.9	25.0	16.5	5.0
	125	155	170	—
	18.0	17.5	15.4	13.3
	16.6	7.8	2.1	—
	160	181	188	225
	280	180	163	—
	199	159	166	130
	21.2	21.4	18.1	10.8
	500	360	347	—
	4.5	4.4	4.7	4.2
	1.9	0.0	2.5	3.1
	11.0	23.1	17.4	12.5
	518	388	372	288
	677	568	560	513
	1,342	1,169	1,093	861
Assets — additional as-filed lines
	1.6	1.6	0.0	—
Trade payables — MSME split
	0.5	2.2	—	—
	199	157	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

GUFICBIO₹423.75

Gufic Biosciences Limited

· Pharma & Health

₹ CrorePeersRPGLIFE UNICHEMLAB GUJTHEM ORCHPHARMA SMSPHARMA INDSWFTLAB FDC IOLCPMcap ₹4,249 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	158.9	153.3	499.6	484.9	484.9
+ Capital Work-in-Progress	169.6	307.1	21.8	22.1	22.1
+ Other Intangibles	—	5.6	6.3	6.2	6.2
+ Non-current Investments	0.8	1.8	1.8	1.8	1.8
+ Long-term Loans	0.3	0.4	0.2	0.5	0.5
+ Other Non-current Financial Assets	—	8.9	9.7	24.8	24.8
Non-current Financial Assets	—	11.1	11.7	27.1	27.1
+ Other Non-current Assets	57.7	15.0	5.3	—	—
Total Non-current Assets	397.1	492.1	544.8	540.3	540.3
Current Assets
+ Inventories	183.5	200.5	216.9	324.5	324.5
+ Trade Receivables	205.5	329.9	314.6	297.4	297.4
+ Cash & Cash Equivalents	28.6	1.1	15.7	62.2	62.2
+ Other Bank Balances	18.1	12.3	13.3	14.0	14.0
+ Short-term Loans	0.2	0.4	0.3	0.7	0.7
+ Other Current Financial Assets	—	0.0	62.1	—	—
Current Financial Assets	252.4	343.8	406.1	374.3	374.3
+ Other Current Assets	28.3	56.2	0.0	101.8	101.8
Total Current Assets	464.1	600.5	624.5	802.1	802.1
Total Assets	861.2	1,092.5	1,169.4	1,342.4	1,342.4
Equity
+ Equity Share Capital	9.7	10.0	10.0	10.0	10.0
+ Other Equity / Reserves	338.1	522.5	591.0	654.9	654.9
Equity — Owners of Parent	347.8	532.6	601.1	664.9	664.9
+ Minority Interest	—	—	0.0	0.0	0.0
Total Equity	347.8	532.6	601.1	665.0	665.0
Liabilities
+ Borrowings — Non-current	190.7	154.0	130.5	105.0	105.0
+ Other Non-current Financial Liab	5.0	16.5	25.0	19.9	19.9
Non-current Financial Liabilities	—	170.5	155.5	125.0	125.0
+ Provisions — Non-current	13.3	15.4	17.5	18.0	18.0
+ Deferred Tax Liabilities	—	2.1	7.8	16.6	16.6
Non-current Liabilities	225.1	187.9	180.7	159.5	159.5
+ Borrowings — Current	—	163.1	179.9	280.1	280.1
+ Trade Payables	130.3	166.3	158.7	199.0	199.0
+ Other Current Financial Liab	10.8	18.1	21.4	21.2	21.2
Current Financial Liabilities	—	347.4	360.0	500.4	500.4
+ Provisions — Current	4.2	4.7	4.4	4.5	4.5
+ Current Tax Liabilities	3.1	2.5	0.0	1.9	1.9
+ Other Current Liabilities	12.5	17.4	23.1	11.0	11.0
Current Liabilities	288.2	372.0	387.6	517.8	517.8
Total Liabilities	513.4	560.0	568.3	677.4	677.4
Total Equity & Liabilities	861.2	1,092.5	1,169.4	1,342.4	1,342.4
Assets — additional as-filed lines
+ Current Tax Assets	—	0.0	1.6	1.6	1.6
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	2.2	0.5	0.5
+ Dues to Other Creditors — Current	—	—	156.5	198.5	198.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.